Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (2329)	9/5/2002 7:08:07 PM
From: Miljenko Zuanic	Read Replies (1) of 2515

<<The german trial will showed reality: erbitux hardly works if at all, the Fda will demand (like it did for Iressa, and Tarceva, and Avastin) large phase III double blind and control subjects to showed increase SURVIVAL.>> Cancer trials and double blind...? Cacaito, get life! Btw, what is your prediction for Iressa? My is positive recommendation by AC. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next